Related Experiment Video
Updated: Jan 15, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Association between NPAR and diabetic kidney disease: Insights from NHANES 2017 to 2020
Zhengxin Liu1, Qin Song1, Yining He1
1Division of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Abstract:
The neutrophil-to-albumin ratio (NPAR) has been identified as an emerging biomarker for systemic inflammation. However, its association with diabetic kidney disease (DKD) remains unclear. This study aims to evaluate the relationship between NPAR and DKD using data from the National Health and Nutrition Examination Survey 2017 to 2020. A total of 8031 participants were included after excluding subjects under 18 years and those with missing data on DKD or NPAR. Participants were categorized based on DKD status. Weighted logistic regression and restricted cubic spline analyses were performed to investigate the association between NPAR and DKD. Higher NPAR levels were significantly associated with increased DKD risk (odds ratio = 2.11, 95% confidence interval: 1.60-2.80, P < .001 in Model 3, adjusted for demographic and clinical covariates). Subgroup analysis indicated that the association was consistent across age, gender, and body mass index categories. Restricted cubic spline analysis suggested a linear relationship between NPAR and DKD risk (P-overall < .001, P-nonlinear = .174). The area under the curve for NPAR predicting DKD was 0.652. Elevated NPAR is associated with an increased prevalence of DKD. However, due to the cross-sectional nature of the study, causality cannot be inferred. These findings highlight the potential of NPAR as an inflammatory marker for DKD risk stratification.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational